Anumana

Cambridge, United States

Anumana develops AI-driven ECG algorithms for early cardiovascular diagnosis and care.

Apr 2025

Series C

Top Investors

Boston ScientificMatrixNTT Venture CapitalnferenceMedTech Innovator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Anumana's investors?

Anumana's investors include Boston Scientific, Matrix, NTT Venture Capital, nference, MedTech Innovator.

Where is Anumana headquartered?

Anumana is headquartered in Cambridge, United States.

What does Anumana do?

Anumana develops AI-driven ECG algorithms for early cardiovascular diagnosis and care.

What stage is Anumana at?

Anumana is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Anumana — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/anumana. Accessed July 1, 2026.

APA

VCBacked. (2025). Anumana — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/anumana

Wikipedia (cite web)

{{cite web |title=Anumana — Funding & Investors |url=https://www.vcbacked.co/company/anumana |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.